Abstract
Background and Aims: PCSK9 inhibitors can reduce LDL cholesterol down to extremely low levels. Despite PCSK9 inhibitors undisputed cardiovascular benefits, a relationship between very low LDL-C and the risk of hemorrhagic transformation (HT) following ischemic stroke has been suggested. The aim of the present study was to assess HT in PCSK9 knockout mice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
